Literature DB >> 2415415

Developmental abnormalities in infants and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex.

M H Ultmann, A L Belman, H A Ruff, B E Novick, B Cone-Wesson, H J Cohen, A Rubinstein.   

Abstract

Children with acquired immune deficiency syndrome (AIDS) display two types of clinical picture: a full-blown AIDS characterized by the presence of opportunistic infections and/or Kaposi's sarcoma and a prodromal stage now identified as AIDS-related complex (ARC). Neurological complications have been identified in infants and children with the disease. This paper discusses the developmental abnormalities in 16 pediatric patients, seven with AIDS and nine with ARC, ranging in age from six months to six years. In all cases, the mothers of these children either had ARC, AIDS and/or used intravenous drugs. Developmental histories showed delayed acquisition of milestones in most children following the diagnosis of AIDS or ARC, with delayed motor milestones consistently noted in both groups. Several children with AIDS actually lost milestones as their illness progressed; this has not occurred in the ARC group. Psychometric testing revealed more severe cognitive dysfunction in the group with AIDS. Involvement of the central nervous system was documented clinically, radiologically, and/or electrophysiologically in all patients with AIDS. In the ARC group the course of the illness has shown greater variability. Medical and social factors that may contribute to the developmental abnormalities are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 2415415     DOI: 10.1111/j.1469-8749.1985.tb14127.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

1.  Oligoclonal T cells are infiltrating the brains of children with AIDS: sequence analysis reveals high proportions of identical beta-chain T-cell receptor transcripts.

Authors:  W L Lin; J E Fincke; L R Sharer; D S Monos; S Lu; J Gaughan; C D Platsoucas; E L Oleszak
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Pediatric AIDS. Neuroradiologic and neurodevelopmental findings.

Authors:  D B Price; C M Inglese; J Jacobs; J O Haller; J Kramer; G C Hotson; J P Loh; D Schlusselberg; R Menez-Bautista; A L Rose
Journal:  Pediatr Radiol       Date:  1988

3.  Dysphagia in the pediatric AIDS population.

Authors:  H Pressman; S H Morrison
Journal:  Dysphagia       Date:  1988       Impact factor: 3.438

Review 4.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

6.  Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection.

Authors:  N Amirhessami-Aghili; S A Spector
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Psycho-social aspects of HIV infection and AIDS in multiple transfused thalassemic children.

Authors:  M A Khan
Journal:  Indian J Pediatr       Date:  1992 Jul-Aug       Impact factor: 1.967

8.  The provision of services to persons with mental retardation and subsequent infection with human immunodeficiency virus (HIV).

Authors:  T A Kastner; M L Hickman; D Bellehumeur
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

9.  Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxis.

Authors:  U A Hunziker; D Nadal; J B Jendis; Z Tomasik; J C Wetzel; J Schüpbach; R A Seger
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

10.  HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Kurt F Hauser; Pamela E Knapp
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.